Frankfurt - Delayed Quote EUR
KALA BIO, Inc. (27F0.F)
2.6940
+0.0820
+(3.14%)
As of 9:24:30 AM GMT+2. Market Open.
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| BAKER BROS ADVISORS, L.P. Beneficial Owner of more than 10% of a Class of Security | Purchase | Dec 30, 2024 | -- |
| BAZEMORE TODD M President | Sale | Jan 6, 2025 | 26,824 |
| BLUMENKRANZ MARK S Director | Stock Award(Grant) | Jun 11, 2024 | 182,821 |
| BRAZZELL ROMULUS KIM Officer | Sale | Jan 6, 2025 | 92,418 |
| IWICKI MARK T. Chief Executive Officer | Sale | Jan 6, 2025 | 280,076 |
| KHARABI DARIUS Officer | Sale | Jan 6, 2025 | 67,807 |
| KOVEN ANDREW IAN Director | Stock Award(Grant) | Jun 11, 2024 | 13,922 |
| PERRY GREGORY D Director | Stock Award(Grant) | Jun 11, 2024 | 10,894 |
| REUMUTH MARY Chief Financial Officer | Sale | Jan 6, 2025 | 68,581 |
| ROSEN HOWARD B Director | Stock Award(Grant) | Jun 11, 2024 | 14,052 |
Related Tickers
ONCT Oncternal Therapeutics, Inc.
0.5266
-24.12%
ACOG Alpha Cognition Inc. Common Stock
5.10
+3.66%
LPTX Leap Therapeutics, Inc.
0.3935
-0.38%
CRIS Curis, Inc.
1.5500
+3.33%
MREO Mereo BioPharma Group plc
2.5000
-2.34%
SWTX SpringWorks Therapeutics, Inc.
41.85
+1.54%
APVO Aptevo Therapeutics Inc.
0.6822
-7.77%
IOVA Iovance Biotherapeutics, Inc.
3.2550
+2.04%
VKTX Viking Therapeutics, Inc.
25.56
-0.89%